- 數據庫(ku)收(shou)錄(lu)SCIE
- 年(nian)發文量(liang)25
Advances In Orthopedics
期刊(kan)中(zhong)文名：骨科進(jin)展ISSN：2090-3464E-ISSN：2090-3472
該雜志國際簡(jian)稱：ADV ORTHOP，是(shi)由(you)出版商Hindawi Limited出版的一(yi)(yi)本致力于發布--研(yan)(yan)究(jiu)新(xin)成(cheng)果的的專業學術(shu)期(qi)刊。主(zhu)要(yao)發表刊登有創(chuang)見的學術(shu)論文文章、行業最新(xin)科研(yan)(yan)成(cheng)果，扼要(yao)報道階段性研(yan)(yan)究(jiu)成(cheng)果和重(zhong)要(yao)研(yan)(yan)究(jiu)工(gong)作的最新(xin)進(jin)展，選載(zai)對學科發展起指導作用的綜(zong)述與專論，促進(jin)學術(shu)發展，為廣(guang)大讀者服務(wu)。該刊是(shi)一(yi)(yi)本國際優秀雜志，在國際上有很(hen)高(gao)的學術(shu)影響(xiang)力。
雜志介紹
Advances In Orthopedics雜志介紹
《Advances In Orthopedics》是一(yi)本(ben)(ben)以English為主(zhu)的(de)開放獲取(qu)國(guo)際優(you)秀期刊(kan)，中文(wen)名(ming)稱骨科(ke)進展，本(ben)(ben)刊(kan)主(zhu)要(yao)出(chu)版、報道領(ling)域的(de)研究動態以及在該(gai)領(ling)域取(qu)得(de)的(de)各(ge)方(fang)面的(de)經(jing)驗和科(ke)研成果，介紹(shao)該(gai)領(ling)域有關本(ben)(ben)專(zhuan)業(ye)的(de)最(zui)新(xin)進展，探討(tao)行(xing)業(ye)發(fa)展的(de)思路和方(fang)法(fa)，以促進學術(shu)信息交流，提高行(xing)業(ye)發(fa)展。該(gai)刊(kan)已被國(guo)際權威數據庫SCIE收(shou)錄，為該(gai)領(ling)域相關學科(ke)的(de)發(fa)展起(qi)到了良好的(de)推(tui)動作(zuo)用，也得(de)到了本(ben)(ben)專(zhuan)業(ye)人員的(de)廣(guang)泛認可。該(gai)刊(kan)最(zui)新(xin)影(ying)響因子為1.2，最(zui)新(xin)CiteScore 指數為2.4。
英文介紹
Advances In Orthopedics雜志英文介紹
Advances in Orthopedics is an international academic journal dedicated to the field of orthopedics, aiming to provide a platform for orthopedic doctors, researchers, and related professionals worldwide to exchange the latest research findings, clinical practices, and technological innovations. This magazine is committed to promoting the development of orthopedic medicine, by publishing high-quality academic papers, promoting a deeper understanding of orthopedic diseases and exploring more effective treatment methods.
The journal has a wide range of content, covering various subfields of orthopedic medicine, including but not limited to trauma orthopedics, joint replacement, spinal surgery, pediatric orthopedics, sports medicine, bone tumors, orthopedic infections, orthopedic rehabilitation, and research on orthopedic biomaterials and biomechanics. The magazine encourages the publication of original research papers, review articles, case reports, technical reports, and clinical trial results, which reflect the cutting-edge dynamics and challenges in the field of orthopedic medicine. As an international journal, it attracts submissions from all over the world, and its articles reflect the latest trends in global orthopedic medical research. By providing an open academic exchange platform, this journal not only promotes communication within the academic community, but also helps clinical doctors understand and apply the latest research findings, thereby improving the diagnosis and treatment of orthopedic diseases. The editorial team is composed of internationally renowned orthopedic experts, who are responsible for ensuring that the published articles have high quality and scientific validity. The editorial board members of the magazine come from different countries and regions, which helps ensure the diversity and international perspective of the journal's content.
JCR分區（2023-2024年最新版）
Advances In Orthopedics雜志 JCR分區信息
| 按JIF指標學科分(fen)區 |
學科：ORTHOPEDICS
收錄子集：ESCI
分區：Q3
排名：94 / 136
百分位：
31.3% |
| 按JCI指標學科分區 |
學科：ORTHOPEDICS
收錄子集：ESCI
分區：Q3
排名：92 / 136
百分位：
32.72% |
JCR分區：JCR分(fen)區(qu)(qu)來自科(ke)(ke)睿唯安公司,JCR是一個(ge)(ge)獨特的(de)(de)多學科(ke)(ke)期(qi)刊評價工具，為(wei)唯一提供基(ji)于引(yin)文數(shu)據(ju)的(de)(de)統計信息的(de)(de)期(qi)刊評價資源(yuan)。每(mei)(mei)年發布的(de)(de)JCR分(fen)區(qu)(qu)，設(she)置了254個(ge)(ge)具體學科(ke)(ke)。JCR分(fen)區(qu)(qu)根(gen)據(ju)每(mei)(mei)個(ge)(ge)學科(ke)(ke)分(fen)類按照期(qi)刊當年的(de)(de)影響(xiang)因子高低(di)將期(qi)刊平均分(fen)為(wei)4個(ge)(ge)區(qu)(qu)，分(fen)別為(wei)Q1、Q2、Q3和Q4，各(ge)占25%。JCR分(fen)區(qu)(qu)中期(qi)刊的(de)(de)數(shu)量是均勻分(fen)為(wei)四個(ge)(ge)部分(fen)的(de)(de)。
CiteScore 評價數據（2024年最新版）
Advances In Orthopedics雜志CiteScore 評價數據
- CiteScore 值：2.4
- SJR：0.438
- SNIP：0.769
| 學科類別 | 分區 | 排名 | 百分位 |
| 大類：Medicine 小類：Orthopedics and Sports Medicine | Q3 | 172 / 321 |
46% |
歷年影響因子和期刊自引率
投稿經驗
Advances In Orthopedics雜志投稿經驗
該(gai)雜(za)志(zhi)是一本國(guo)(guo)(guo)際(ji)優秀雜(za)志(zhi)，在國(guo)(guo)(guo)際(ji)上有較高的(de)學(xue)術(shu)影響力，行業(ye)關注度很高，已被(bei)國(guo)(guo)(guo)際(ji)權威(wei)數據(ju)庫SCIE收錄(lu)，該(gai)雜(za)志(zhi)在綜合專(zhuan)業(ye)領域專(zhuan)業(ye)度認可很高，對稿(gao)(gao)(gao)件內容的(de)創(chuang)新性(xing)和(he)學(xue)術(shu)性(xing)要求很高，作為一本國(guo)(guo)(guo)際(ji)優秀雜(za)志(zhi)，一般投(tou)稿(gao)(gao)(gao)過(guo)審(shen)時(shi)間(jian)(jian)都較長(chang)，投(tou)稿(gao)(gao)(gao)過(guo)審(shen)時(shi)間(jian)(jian)平均 21 Weeks ，如果(guo)想(xiang)(xiang)投(tou)稿(gao)(gao)(gao)該(gai)刊要做好時(shi)間(jian)(jian)安排。版(ban)面費不(bu)祥。該(gai)雜(za)志(zhi)近兩年未(wei)被(bei)列入預警名單，建(jian)議您(nin)投(tou)稿(gao)(gao)(gao)。如您(nin)想(xiang)(xiang)了解更多投(tou)稿(gao)(gao)(gao)政策及投(tou)稿(gao)(gao)(gao)方(fang)案，請(qing)咨詢客服。
免責聲明
若用(yong)戶需(xu)要出(chu)版服(fu)務，請聯(lian)系出(chu)版商。